A 5:2 intermittent fasting regimen initiated in the active phase ameliorates NASH, fibrosis and blunts HCC development via hepatic PPARα and PCK1

Accession: GSE255356
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Transcriptomic, subtype: bulk RNA-seq)
Modality / assay: bulk-RNAseq
Platform: Expression profiling by high throughput sequencing, 24247
Organism: mouse
Samples: 39
Size (indexed): (None bytes)
Downloaded bytes: 38.3 MB (40165249 bytes)
Access / raw: public /

Download

  • Source URL: https://ftp.ncbi.nlm.nih.gov/geo/series/GSE255nnn/GSE255356/suppl/
  • PMIDs: 38718791

Files

FileSizeSHA256
GSE255356_RAW.tar35.9 MBa0be562a33142830…
GSE255356_rsem.merged.gene_counts.tsv.gz2.4 MB583f5002e9477bff…
filelist.txt3.1 KBdbfd195919f658fa…

Crawled by masld-atlas-crawler v1.0 at 2026-08-06T06:48:23Z.

Tags
MouseSingle CellMASLD
Product
Expression profiling by high throughput sequencing, 24247
Species
mouse
Anatomical entity
Liver
Disease state
MASLD/NAFLD/NASH
Cell/nuclei count
39
Date published
—
Files
3
Total size
38.3 MB